CODEXIS INC. - COMMON STOCK

Codexis to Report Second Quarter 2021 Financial Results on August 5

22 Jul 2021 16:05:01 By Nasdaq GlobeNewswire

Codexis Announces Completion of CodeEvolver® License Technology Transfer with Global Pharmaceutical Leader

14 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Earns Milestone Payment from GlaxoSmithKline

07 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme Product

17 Jun 2021 16:44:08 By Nasdaq GlobeNewswire

Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic Disorder

10 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

25 May 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

17 May 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Reports First Quarter 2021 Financial Results

06 May 2021 16:05:01 By Nasdaq GlobeNewswire

Codexis to Report First Quarter 2021 Financial Results on May 6

22 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results

25 Feb 2021 16:05:03 By Nasdaq GlobeNewswire

Codexis to Present at Upcoming Virtual Healthcare Conferences

18 Feb 2021 16:05:01 By Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Full Year 2020 Results on February 25

11 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth

09 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Appoints Dr. Esther Martinborough to its Board of Directors

03 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production

13 Jan 2021 07:00:00 By Nasdaq GlobeNewswire

Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference

05 Jan 2021 07:00:00 By Nasdaq GlobeNewswire